FDA OKs nonprescription defibrillators

被引：0

|

作者：

Mitka, M

机构：

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2004年 / 292卷 / 15期

关键词：

D O I：

10.1001/jama.292.15.1809

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1809 / 1809

页数：1

相关论文

共 50 条

[21] FDA advisers vote against nonprescription lovastatin
Traynor, K
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (05) : 455 - +
[22] FDA advisers again reject nonprescription lovastatin
Traynor, Kate
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (02) : 101 - +
[23] FDA OKs first in vitro route to expanded approval
Katie Kingwell
Nature Reviews Drug Discovery, 2017, 16 : 591 - 592
[24] FDA OKs first orally disintegrating tablet for ADHD
不详
NURSE PRACTITIONER, 2016, 41 (04): : 56 - 56
[25] FDA mulls expanded universe of nonprescription drugs
Traynor, Kate
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2012, 69 (09) : 734 - 735
[26] FDA panel OKs combination therapy for relapsing HCV
Fox, S
INFECTIONS IN MEDICINE, 1998, 15 (06) : 356 - 356
[27] FDA OKs first in vitro route to expanded approval
Kingwell, Katie
NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (09) : 591 - 592
[28] FDA OKs cheap home virus tests DIAGNOSTICS
Brainard, Jeffrey
SCIENCE, 2021, 372 (6538) : 110 - 110
[29] FDA RESCINDS NONPRESCRIPTION STATUS OF COMBINATION PROMETHAZINE PRODUCTS
不详
CLINICAL PHARMACY, 1989, 8 (12): : 830 - 831
[30] FDA BANS 223 INGREDIENTS IN NONPRESCRIPTION DRUG PRODUCTS
不详
CLINICAL PHARMACY, 1991, 10 (02): : 88 - &

← 1 2 3 4 5 →